The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab, radiotherapy, and chemotherapy in neoadjuvant treatment of malignant esophago-gastric diseases (PROCEED): Assessment of pathologic response and toxicity in a prospective, phase II single-arm trial.
 
Pooja Karukonda
No Relationships to Disclose
 
Brian G. Czito
Honoraria - Varian Medical Systems
 
Eileen Duffy
No Relationships to Disclose
 
Hope Elizabeth Uronis
Employment - GeneCentric (I)
Stock and Other Ownership Interests - GeneCentric (I)
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Medarex
Research Funding - Adaptimmune (Inst); Arcus Biosciences (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Leap Therapeutics (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Thomas A. D'Amico
Honoraria - Medtronic
Consulting or Advisory Role - Scanlan
Travel, Accommodations, Expenses - Medtronic
 
John H Strickler
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Beigene; Daiichi Sankyo/Astra Zeneca; GlaxoSmithKline; Inivata; Lilly; Natera (Inst); Pfizer; Pionyr; Roche/Genentech; Seagen; Silverback Therapeutics; Takeda; Viatris; Zentalis
Research Funding - A*STAR (Inst); Abbvie (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); BeiGene; Curegenix (Inst); Daiichi Sankyo/Lilly; Erasca, Inc (Inst); Leap Therapeutics (Inst); Lilly (Inst); Nektar (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Silverback Therapeutics (Inst)
Travel, Accommodations, Expenses - Seagen
 
Donna Niedzwiecki
No Relationships to Disclose
 
Christopher Willett
No Relationships to Disclose
 
Manisha Palta
Employment - Duke University
Honoraria - Oakstone
Consulting or Advisory Role - Syntactx; VoxelMetrix
Research Funding - Galera Therapeutics (Inst); Merck (Inst); Varian Medical Systems (Inst)
Patents, Royalties, Other Intellectual Property - Up to Date- Annual royalties for being a section author